Evidence map›Paper›PMID 29791442›Full record

ArticlePloS one2018

Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey.

Benjamin Glasset, Sabine Herbin, Sophie A Granier, Laurent Cavalié, Emilie Lafeuille, Cyprien Guérin, Raymond Ruimy, Florence Casagrande-Magne, Marion Levast, Nathalie Chautemps and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pathogenesis of human-derivedFrontiers in cellular and infection microbiology · 2026
    Article
  11. Article
  12. Genomic epidemiology of aMicrobial genomics · 2025
    Article
  13. The Majority ofOpen forum infectious diseases · 2025
    Article
  14. Article
  15. Article
  16. Optimizing MALDI-TOF Mass Spectrometry for the Identification ofInternational journal of molecular sciences · 2025
    Article
  17. Genetic diversity and virulence ofMicrobiology spectrum · 2025
    Article
  18. Article
  19. Article
  20. Microbiological and molecular analysis of the microbiota of insects present in the surgical area.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Benjamin GlassetMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Sabine HerbinUniversité Paris-Est, Anses, Laboratory for Food Safety, Maisons-Alfort, France.
Sophie A GranierUniversité Paris-Est, Anses, Laboratory for Food Safety, Maisons-Alfort, France.
Laurent CavaliéCHU Toulouse, Service de Bactériologie-Hygiène, IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
Emilie LafeuilleSorbonne Universités, UPMC Univ Paris 06, Inserm, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
Cyprien GuérinMaiAGE, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.
Raymond RuimyCHU Nice, Laboratoire de bactériologie, Nice, France.
Florence Casagrande-MagneCHU Nice, Laboratoire de bactériologie, Nice, France.
Marion LevastHôpital de Chambéry, Laboratoire de Biologie Médicale, Chambéry, France.
Nathalie ChautempsHôpital de Chambéry, Laboratoire de Biologie Médicale, Chambéry, France.
Jean-Winoc DecousserHôpitaux Universitaires Paris-Sud Antoine Béclère, Laboratoire Hygiène, Clamart, France.
Laure BelottiCHU Strasbourg, Laboratoire d'hygiène hospitalière, Strasbourg, France.
Isabelle PellouxCHU Grenoble, Laboratoire de Bactériologie, Grenoble, France.
Jerôme RobertSorbonne Universités, UPMC Univ Paris 06, Inserm, U1135, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.
Anne BrisaboisUniversité Paris-Est, Anses, Laboratory for Food Safety, Maisons-Alfort, France.
Nalini RamaraoMicalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.ORCID 0000-0001-6045-8521
Agence Nationale des Fréquences · FRAgroParisTech · FRCentre Hospitalier Métropole Savoie · FRCentre Hospitalier Universitaire de Nice · FRInserm · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Grenoble · FRHôpital Antoine-Béclère · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacillus cereus is the 2nd most frequent bacterial agent responsible for food-borne outbreaks in France and the 3rd in Europe. In addition, local and systemic infections have been reported, mainly describing individual cases or single hospital setting. The real incidence of such infection is unknown and information on genetic and phenotypic characteristics of the incriminated strains is generally scarce. We performed an extensive study of B. cereus strains isolated from patients and hospital environments from nine hospitals during a 5-year study, giving an overview of the consequences, sources and pathogenic patterns of B. cereus clinical infections. We demonstrated the occurrence of several hospital-cross-contaminations. Identical B. cereus strains were recovered from different patients and hospital environments for up to 2 years. We also clearly revealed the occurrence of inter hospital contaminations by the same strain. These cases represent the first documented events of nosocomial epidemy by B. cereus responsible for intra and inter hospitals contaminations. Indeed, contamination of different patients with the same strain of B. cereus was so far never shown. In addition, we propose a scheme for the characterization of B. cereus based on biochemical properties and genetic identification and highlight that main genetic signatures may carry a high pathogenic potential. Moreover, the characterization of antibiotic resistance shows an acquired resistance phenotype for rifampicin. This may provide indication to adjust the antibiotic treatment and care of patients.

Indexed as

PhenotypeSurveys and QuestionnairesAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBacillus cereusChildChild, PreschoolCross InfectionFemaleGenetic VariationGenomicsHumansInfantAnti-Bacterial Agents

Identifiers

PMID29791442
PMCPMC5966241
OpenAlexW2804167320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.